Martin Teintze - Publications

Affiliations: 
Montana State University, Bozeman, MT 
Area:
Biochemistry

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Pomwised R, Intamaso U, Teintze M, Young M, Pincus SH. Coupling Peptide Antigens to Virus-Like Particles or to Protein Carriers Influences the Th1/Th2 Polarity of the Resulting Immune Response. Vaccines. 4. PMID 27164150 DOI: 10.3390/Vaccines4020015  0.634
2014 Weaver AJ, Shepard JB, Wilkinson RA, Watkins RL, Walton SK, Radke AR, Wright TJ, Awel MB, Cooper C, Erikson E, Labib ME, Voyich JM, Teintze M. Antibacterial activity of THAM Trisphenylguanide against methicillin-resistant Staphylococcus aureus. Plos One. 9: e97742. PMID 24840307 DOI: 10.1371/Journal.Pone.0097742  0.701
2014 Shepard JB, Wilkinson RA, Starkey JR, Teintze M. Novel guanide-substituted compounds bind to CXCR4 and inhibit breast cancer metastasis. Anti-Cancer Drugs. 25: 8-16. PMID 24045366 DOI: 10.1097/Cad.0000000000000019  0.709
2013 Wilkinson RA, Pincus SH, Song K, Shepard JB, Weaver AJ, Labib ME, Teintze M. Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection. Bioorganic & Medicinal Chemistry Letters. 23: 2197-201. PMID 23434419 DOI: 10.1016/J.Bmcl.2013.01.107  0.73
2011 Wilkinson RA, Pincus SH, Shepard JB, Walton SK, Bergin EP, Labib M, Teintze M. Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4. Antimicrobial Agents and Chemotherapy. 55: 255-63. PMID 20937786 DOI: 10.1128/Aac.00709-10  0.733
2007 Wilkinson RA, Evans JR, Jacobs JM, Slunaker D, Pincus SH, Pinter A, Parkos CA, Burritt JB, Teintze M. Peptides selected from a phage display library with an HIV-neutralizing antibody elicit antibodies to HIV gp120 in rabbits, but not to the same epitope. Aids Research and Human Retroviruses. 23: 1416-27. PMID 18184085 DOI: 10.1089/Aid.2007.0027  0.657
2006 Teintze M, Wilkinson R, Grieco P, Mills J, Dratz E. CCR5 and CXCR4 antagonist and agonist binding sites Retrovirology. 3: 1-1. DOI: 10.1186/1742-4690-3-S1-S39  0.406
2005 Wilkinson RA, Piscitelli C, Teintze M, Cavacini LA, Posner MR, Lawrence CM. Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120. Journal of Virology. 79: 13060-9. PMID 16189008 DOI: 10.1128/Jvi.79.20.13060-13069.2005  0.322
2005 Teintze M, Wilkinson R, Grieco P, Mills J, Dratz E. CCR5 Antagonist and Agonist Binding Site Structures Retrovirology. 2: 93. DOI: 10.1186/1742-4690-2-S1-P93  0.395
2003 Jacobs JM, Bailey BW, Burritt JB, Morrison SG, Morrison RP, Dratz EA, Jesaitis AJ, Teintze M. QSYP peptide sequence is selected from phage display libraries by bovine IgG contaminants in monoclonal antibody preparations. Biotechniques. 34: 132-4, 137-41. PMID 12545550 DOI: 10.2144/03341Rr04  0.604
2002 Chasan B, Geisse NA, Pedatella K, Wooster DG, Teintze M, Carattino MD, Goldmann WH, Cantiello HF. Evidence for direct interaction between actin and the cystic fibrosis transmembrane conductance regulator. European Biophysics Journal : Ebj. 30: 617-24. PMID 11908853 DOI: 10.1007/S00249-001-0188-9  0.677
2000 Kazmin DA, Hoyt TR, Taubner L, Teintze M, Starkey JR. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1. Journal of Molecular Biology. 298: 431-45. PMID 10772861 DOI: 10.1006/Jmbi.2000.3680  0.689
1996 Pincus SH, Wehrly K, Cole R, Fang H, Lewis GK, McClure J, Conley AJ, Wahren B, Posner MR, Notkins AL, Tilley SA, Pinter A, Eiden L, Teintze M, Dorward D, et al. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160 Aids Research and Human Retroviruses. 12: 1041-1051. PMID 8827220 DOI: 10.1089/Aid.1996.12.1041  0.407
Show low-probability matches.